Filing Flows › Tarsus Pharmaceuticals (TARS) › Free cash flow
Tarsus Pharmaceuticals (TARS) free cash flow by quarter
Tarsus Pharmaceuticals' free cash flow was $57.2M in Q2 2026 (second quarter 2026), +341% from Q4 2025. Over the last 3 quarters it ranged from $13.0M (Q4 2025) to $57.2M (Q2 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $57.2M | +341% | — |
| Q4 2025 | $13.0M | -21% | — |
| Q3 2025 | $16.3M | — | — |
Q2 2026 at a glance
Tarsus Pharmaceuticals, Q2 2026: revenue $174M (+69% year over year), operating margin -11.4%, net loss $18.6M, operating cash flow $61.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Tarsus Pharmaceuticals' free cash flow?
Tarsus Pharmaceuticals' free cash flow was $57.2M in Q2 2026 (second quarter 2026), +341% from Q4 2025.
How has Tarsus Pharmaceuticals' free cash flow changed?
Over the last 3 quarters it ranged from $13.0M (Q4 2025) to $57.2M (Q2 2026).
Q2 2026 results → · How Tarsus Pharmaceuticals makes money →